Docoh
Loading...

DNMR Danimer Scientific

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On December 28, 2020, Live Oak Acquisition Corp. (the “Company”) held a virtual special meeting (the “Special Meeting”) in connection with the proposed business combination (the “Business Combination”) of the Company and Meredian Holdings Group, Inc., doing business as Danimer Scientific (“Danimer”), as described in the proxy statement/prospectus filed by the Company with the SEC on December 16, 2020 (the “Proxy Statement”) and incorporated herein by reference. Present at the Special Meeting were holders of 11,954,778 shares of the Company’s Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”) and 5,000,000 shares of the Company’s Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock” and, together with the Class A Common Stock, the “Common Stock”), in person (online) or by proxy, representing 67.82% of the voting power of the Common Stock as of December 7, 2020, the record date for the Special Meeting (the “Record Date”), and constituting a quorum for the transaction of business. As of the Record Date, there were 20,000,000 shares of Class A Common Stock and 5,000,000 shares of Class B Common Stock issued and outstanding.

At the Special Meeting, the Company’s stockholders approved the Business Combination Proposal, the Charter Amendment Proposal (including each sub-proposal), the Election of Directors Proposal, the NYSE Proposal, the Equity Incentive Plan Proposal, the Employee Stock Purchase Plan Proposal and the Adjournment Proposal, in each case as defined and described in greater detail in the Proxy Statement.

The approval of the Business Combination Proposal, the NYSE Proposal, the Equity Incentive Plan Proposal, the Employee Stock Purchase Plan Proposal and the Adjournment Proposal required the affirmative vote of the majority of the votes cast by holders of shares of the Class A Common Stock and Class B Common Stock, voting as a single class, represented at the Special Meeting in person or by proxy. The approval of the Charter Amendment Proposal (including each sub-proposal) required the affirmative vote of the holders of a majority of the Company’s outstanding shares of Class A Common Stock and Class B Common Stock, voting as a single class, entitled to vote thereon at the Special Meeting. The approval of the election of each director nominee pursuant to the Election of Directors Proposal required the affirmative vote of the holders of a plurality of the outstanding shares of Class A Common Stock entitled to vote and actually cast thereon at the Special Meeting. The Business Combination Proposal, the Charter Amendment Proposal (including each sub-proposal), the Election of Directors Proposal, the NYSE Proposal, the Equity Incentive Plan Proposal, the Employee Stock Purchase Plan Proposal and the Adjournment Proposal each received a sufficient number of votes for approval.

Set forth below are the final voting results for the Business Combination Proposal, the Charter Amendment Proposal, the Election of Directors Proposal, the NYSE Proposal, the Equity Incentive Plan Proposal, the Employee Stock Purchase Plan Proposal and the Adjournment Proposal:

Business Combination Proposal

The Business Combination Proposal was approved. The voting results of the shares of the Common Stock were as follows:

ForAgainstAbstentions
16,933,15480020,824


The Charter Amendment Proposal

The Charter Amendment Proposal was approved. The voting results of the shares of the Common Stock for each of the sub-proposals were as follows:

(a)To change the Company’s name to “Danimer Scientific, Inc.”:


ForAgainstAbstentions
16,934,15480019,824


(b)To revise the Company’s purpose:


ForAgainstAbstentions
16,932,58280021,396


(c)To increase the number of authorized shares to 210,000,000 shares consisting of (i) 200,000,000 shares of Class A Common Stock and (ii) 10,000,000 shares of preferred stock:


ForAgainstAbstentions
16,923,9111,52029,347


(d)To remove the business combination requirements:


ForAgainstAbstentions
16,926,20682327,749


(e)To revise the choice of forum provision:


ForAgainstAbstentions
16,925,65780028,321


(f)To add the supermajority voting provisions:


ForAgainstAbstentions
14,853,7332,070,70430,341


(g)To remove the provision renouncing the corporate opportunity doctrine:


ForAgainstAbstentions
16,921,37780032,601


(h)To remove the provisions providing for a classified board of directors:


ForAgainstAbstentions
16,923,10088630,792


(i)To approve all other changes.


ForAgainstAbstentions
16,924,9291,18128,668


The Election of Directors Proposal

The election of each director nominee pursuant to the Election of Directors Proposal was approved. The voting results of the shares of the Common Stock for the director nominees were as follows:

Stephen E. Croskrey

ForWithheld
16,935,06619,712


John P. Amboian

ForWithheld
16,769,274185,504


Richard J. Hendrix

ForWithheld
16,935,06919,709


Christy Basco

ForWithheld
16,926,56628,212


Phillip Gregory Calhoun

ForWithheld
16,935,06919,709


Gregory Hunt

ForWithheld
16,935,06919,709


Dr. Isao Noda

ForWithheld
16,927,06927,709


Stuart Pratt

ForWithheld
14,694,0812,260,697




The NYSE Proposal

The NYSE Proposal was approved. The voting results of the shares of the Common Stock were as follows:

ForAgainstAbstentions
16,191,2553,60031,923




The Equity Incentive Plan Proposal

The Equity Incentive Plan Proposal was approved. The voting results of the shares of the Common Stock were as follows:

ForAgainstAbstentions
16,916,4175,73532,626




The Employee Stock Purchase Plan Proposal

The Employee Stock Purchase Plan Proposal was approved. The voting results of the shares of the Common Stock were as follows:

ForAgainstAbstentions
16,922,3094,10128,368




The Adjournment Proposal

The Adjournment Proposal was approved. The voting results of the shares of the Common Stock were as follows:

ForAgainstAbstentions
14,856,8552,067,99329,930